Total Insulin No insulin
Patients (n) 87 51 36
Age (years) (SD) 57.88 (9.96) 58.01 (8.98) 57.71 (11.34)
Male/Female (%) 39.07/60.93 39.22/60.78 38.89/61.11
Creatinine (mg/dl) (SD) 0.83 (0.27) 0.89 (0.28) 0.79 (0.27)
eGFR (mL/min/1.73m2) (SD) 88.10 (±26.47) 82.81 (±28.33) 92.72 (±25.19)
Initiating treatment, n (%)
Metformin
72 (82.75)
39 (76.47)
33 (91.66)
Sulfonylureas
23 (26.43)
13 (25.49)
10 (27.77)
DPP-4i
31 (35.63)
20 (39.21)
11 (30.55)
SGLT2i
31 (35.63)
15 (29.41)
16 (44.44)
Insulin
51 (58.62)
51 (100)
36 (0)
ACEIs/ARBs
68 (78.16)
43 (84.31)
25 (69.44)
Diuretics
50 (57.47)
29 (56.86)
21 (58.33)
Antihyperglycemic drugs (without insulin), n (%)
0
5 (5.74)
4 (7.84)
1 (2.77)
1
31 (35.63)
18 (35.29)
13 (36.11)
2
32 (36.78)
19 (37.25)
13 (36.11)
≥3
19 (21.84)
10 (19.60)
9 (25)
Glucose (mg/dl) (SD) 174.22 (66.25) 175.91 (72.79) 162.89 (46.99)
HbA1c (%) (SD) 8.53 (1.91) 8.87 (1.97) 7.81 (1.42)
Weight (kg) (SD) 102.20 (19.64) 98.68 (14.38) 108.66 (26.02)